Follow us

  • X
  • Youtube

News Release

Release
Notice of Cancellation of the Share Purchase Agreement with Evo Fund
Release
Notice of Cancellation of the 4th Stock Issuance in Private Placement Offerings
Release
GNI Announces Strategy for Seeking Early Conditional Approval of F647 for the treatment of Idiopathic Pulmonary Fibrosis in China
Release
Notice of Cancellation of the 3rd Stock Issuance in Private Placement Offerings
Release
Notice of the Resignation of the Auditor and the Inauguration of the Officer
Release
Notice of Payment for Allocation of New Shares to a Third Party
Release
Notice of Amendment of Earnings Forecast
Release
Notice of Cancellation of the 2nd Stock Issuance in Private Placement Offerings
Release
Amendment of Notification of Major Shareholder Change
Release
Announcement of Changes in Titles of the Management
Release
GNI Announces Restructuring to Streamline Operation and to Reduce Cost; CEO Luo Succeeds President
Release
Notice of Stock Issuance in Private Placement Offering
Information
Pharma Focus Asia Published an article “Breaking Down Borders Asian biotechnology industry” authorized by Dr. Ying Luo in its July issue http://www.pharmafocusasia.com/magazine/
Information
New Ubiquitin-Mediated Protein Degradation Mechanism Published by Scientists in Shanghai
Release
Amendment of Share Purchase Commitment Agreement with Evo Fund